×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LIVN – livanova plc - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LIVN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/9
10:09 am
livn
LivaNova (NASDAQ:LIVN) was given a new $67.00 price target on by analysts at Barclays PLC.
Low
Report
LivaNova (NASDAQ:LIVN) was given a new $67.00 price target on by analysts at Barclays PLC.
1/9
07:00 am
livn
LivaNova (NASDAQ:LIVN) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Low
Report
LivaNova (NASDAQ:LIVN) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
1/8
11:46 am
livn
Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 28%? [Yahoo! Finance]
Low
Report
Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 28%? [Yahoo! Finance]
1/8
02:03 am
livn
The Brain: From Black Box To Engineering Problem [Seeking Alpha]
Low
Report
The Brain: From Black Box To Engineering Problem [Seeking Alpha]
1/7
09:24 am
livn
LivaNova (NASDAQ:LIVN) had its price target raised by analysts at Stifel Nicolaus from $65.00 to $70.00. They now have a "buy" rating on the stock.
Low
Report
LivaNova (NASDAQ:LIVN) had its price target raised by analysts at Stifel Nicolaus from $65.00 to $70.00. They now have a "buy" rating on the stock.
12/23
09:17 am
livn
LivaNova to Present at J.P. Morgan Healthcare Conference in January [Yahoo! Finance]
Low
Report
LivaNova to Present at J.P. Morgan Healthcare Conference in January [Yahoo! Finance]
12/23
09:00 am
livn
LivaNova to Present at J.P. Morgan Healthcare Conference in January
Low
Report
LivaNova to Present at J.P. Morgan Healthcare Conference in January
12/22
06:00 am
livn
Cadence Neuroscience Announces Medical Device Veteran Daniel Moore as Independent Board Director
Low
Report
Cadence Neuroscience Announces Medical Device Veteran Daniel Moore as Independent Board Director
Date
Time
Symbol
Company Name
Action
%Chg
11/5/2025
06:00 am
livn
livanova plc - ordinary shares
BEAT
Report
-7.6%
livanova plc - ordinary shares
8/6/2025
06:00 am
livn
livanova plc - ordinary shares
BEAT
Report
11.1%
livanova plc - ordinary shares
5/7/2025
06:00 am
livn
livanova plc - ordinary shares
BEAT
Report
18.2%
livanova plc - ordinary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/14
08:33 am
livn
Form 8-K LivaNova PLC For: Jan 12
Low
Report
Form 8-K LivaNova PLC For: Jan 12
12/17
04:06 pm
livn
Form 4 LivaNova PLC For: Dec 15 Filed by: Poletti Franco
Low
Report
Form 4 LivaNova PLC For: Dec 15 Filed by: Poletti Franco
12/17
04:06 pm
livn
Form 4 LivaNova PLC For: Dec 15 Filed by: Hutchinson Michael Damon
Low
Report
Form 4 LivaNova PLC For: Dec 15 Filed by: Hutchinson Michael Damon
12/17
04:06 pm
livn
Form 4 LivaNova PLC For: Dec 15 Filed by: PODLOGAR SUSAN M
Low
Report
Form 4 LivaNova PLC For: Dec 15 Filed by: PODLOGAR SUSAN M
11/19
03:57 pm
livn
Form 4 LivaNova PLC For: Nov 18 Filed by: Story Brooke
Low
Report
Form 4 LivaNova PLC For: Nov 18 Filed by: Story Brooke
11/18
04:51 pm
livn
Form 144 LivaNova PLC Filed by: Story Brooke
Low
Report
Form 144 LivaNova PLC Filed by: Story Brooke
11/6
04:19 pm
livn
Form SCHEDULE 13G/A LivaNova PLC Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Low
Report
Form SCHEDULE 13G/A LivaNova PLC Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/24
LivaNova PLC (NASDAQ: LIVN) had its price target lowered by analysts at Stifel Nicolaus from $80.00 to $40.00. They now have a "buy" rating on the stock.
9.1%
2/26 LivaNova Enters Research Collaboration with Verily to Gain New Insights into Vagus Nerve Stimulation Impact on Difficult-to-Treat Depression 7.3%
3/3 Form 4 LivaNova PLC For: Mar 01 Filed by: McDonald Damien 7.0%
3/13 LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.1%
4/25 LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 6.1%
4/1 Form 4 LivaNova PLC For: Mar 30 Filed by: Skeffington Keyna Pidcock 5.7%
3/30 LivaNova to Host Conference Call for First Quarter 2020 Results 5.0%
9/5 LivaNova Receives Approval from U.S. Centers for Medicare & Medicaid Services for RECOVER Clinical Study 4.7%
11/25 LivaNova PLC (NASDAQ: LIVN) had its price target raised by analysts at Stifel Nicolaus from $80.00 to $90.00. They now have a "buy" rating on the stock. 4.6%
3/26 LivaNova Autonomic Regulation Therapy for Heart Failure Findings to be Presented at American College of Cardiology and World Congress of Cardiology Virtual Meeting 4.0%
2/26 LivaNova Enters Research Collaboration with Verily to Gain New Insights into Vagus Nerve Stimulation Impact on Difficult-to-Treat Depression 7.3%
3/3 Form 4 LivaNova PLC For: Mar 01 Filed by: McDonald Damien 7.0%
3/13 LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.1%
4/25 LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 6.1%
4/1 Form 4 LivaNova PLC For: Mar 30 Filed by: Skeffington Keyna Pidcock 5.7%
3/30 LivaNova to Host Conference Call for First Quarter 2020 Results 5.0%
9/5 LivaNova Receives Approval from U.S. Centers for Medicare & Medicaid Services for RECOVER Clinical Study 4.7%
11/25 LivaNova PLC (NASDAQ: LIVN) had its price target raised by analysts at Stifel Nicolaus from $80.00 to $90.00. They now have a "buy" rating on the stock. 4.6%
3/26 LivaNova Autonomic Regulation Therapy for Heart Failure Findings to be Presented at American College of Cardiology and World Congress of Cardiology Virtual Meeting 4.0%
TOP News Decliners
3/17
Form 4 LivaNova PLC For: Mar 15 Filed by: Huston Thad Allen
-15.0%
3/20 LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -8.4%
3/9 LivaNova VNS Therapy System, Symmetry, Granted CE Mark for Difficult-to-Treat Depression -6.3%
2/26 Q4/2019 12/31/2019 EPS 1.000 ZacksConsensus 0.950 ActVsEst 0.050 - Beat -5.9%
4/29 Q1/2020 3/31/2020 EPS 0.330 ZacksConsensus 0.340 ActVsEst (0.010) - Miss -5.0%
10/30 Q3/2019 9/30/2019 EPS 0.840 ZacksConsensus 0.720 ActVsEst 0.120 - Beat -4.8%
10/2 LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -3.7%
3/6 LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -3.1%
9/17 Form 4 LivaNova PLC For: Sep 15 Filed by: Hebbelinck Trui -2.9%
2/8 LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -2.7%
3/20 LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -8.4%
3/9 LivaNova VNS Therapy System, Symmetry, Granted CE Mark for Difficult-to-Treat Depression -6.3%
2/26 Q4/2019 12/31/2019 EPS 1.000 ZacksConsensus 0.950 ActVsEst 0.050 - Beat -5.9%
4/29 Q1/2020 3/31/2020 EPS 0.330 ZacksConsensus 0.340 ActVsEst (0.010) - Miss -5.0%
10/30 Q3/2019 9/30/2019 EPS 0.840 ZacksConsensus 0.720 ActVsEst 0.120 - Beat -4.8%
10/2 LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -3.7%
3/6 LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -3.1%
9/17 Form 4 LivaNova PLC For: Sep 15 Filed by: Hebbelinck Trui -2.9%
2/8 LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -2.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: